Cheng-Hock Toh: The Paradox of Hematology
Cheng-Hock Toh, Chair at National Blood Transfusion Committee,Professor of Medical Haematology at the University of Liverpool and Liverpool University Hospitals NHS Foundation Trust, shared on LinkedIn about a recent article he and Elisabeth Buggins co-authored, adding:
“The Visibility Problem
The Paradox of Hematology:
Because it is involved in everything, it is recognised in nothing.
- Abnormal bloods? ‘Ask haematology.’
- Clotting issue? ‘Ask haematology.’
- Transfusion problem? ‘Haematology should fix it.’
- Chemotherapy complication? ‘Haematology input needed.’
Yet haematology is rarely present in:
- digital design discussions
- workforce planning
- strategic NHS conversations
This invisibility has consequences — for safety, staffing and sustainability.
- We saw this clearly in transfusion practice.
- We see it in anticoagulation.
- We see it across cancer pathways.
When the discipline at the centre of medicine is treated as peripheral, systems begin to fail at the edges.”
Title: Transfusion safety continues to be compromised in the NHS
Authors: Cheng-Hock Toh, Elisabeth Buggins
Read the Full Article on The British Medical Journal.
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 12:37Rutuja Mahadik: Anemia is More Than Just Feeling Tired
-
Jun 1, 2026, 12:36Ankur Jindal: Large-Vessel Inflammation and Immune Dysregulation in Wiskott–Aldrich Syndrome
-
Jun 1, 2026, 12:35Shadi Almassri: Conditions That Can Cause False High or False Low HbA1c Results
-
Jun 1, 2026, 12:22Ed Davidson: Clot Removing Technology That Can Change the Game
-
Jun 1, 2026, 12:17Tagreed Alkaltham: Building Blood Systems for Both Efficiency and Resilience
-
Jun 1, 2026, 11:16Ocima Richard Draza: Postpartum Hemorrhage – A Practical Step-by-Step Management Guide
-
Jun 1, 2026, 10:57Kyungjun Lim: How Will Future Mars Colonies Manage Their Supply Chains?
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?